within Pharmacolibrary.Drugs.ATC.D;

model D07AC01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 2e-06,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.010833333333333334,
    Tlag           = 600,            
    Vdp             = 0.0045,
    k12             = 0.1,
    k21             = 0.1
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D07AC01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Betamethasone is a potent synthetic glucocorticoid corticosteroid used for its anti-inflammatory and immunosuppressive effects. It is widely approved for the treatment of various inflammatory, allergic, and autoimmune conditions, as well as for fetal lung maturation in preterm labor. Betamethasone is available in topical, oral, parenteral, and intramuscular formulations.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adult healthy volunteers receiving a single oral dose of betamethasone.</p><h4>References</h4><ol><li><p>Jobe, AH, et al., &amp; Jusko, WJ (2020). Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India. <i>Clinical and translational science</i> 13(2) 391–399. DOI:<a href=\"https://doi.org/10.1111/cts.12724\">10.1111/cts.12724</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31808984/\">https://pubmed.ncbi.nlm.nih.gov/31808984</a></p></li><li><p>Schmidt, AF, et al., &amp; Kemp, MW (2019). Oral antenatal corticosteroids evaluated in fetal sheep. <i>Pediatric research</i> 86(5) 589–594. DOI:<a href=\"https://doi.org/10.1038/s41390-019-0519-0\">10.1038/s41390-019-0519-0</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31365919/\">https://pubmed.ncbi.nlm.nih.gov/31365919</a></p></li><li><p>Krzyzanski, W, et al., &amp; Jusko, WJ (2021). Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women. <i>Journal of pharmacokinetics and pharmacodynamics</i> 48(2) 261–272. DOI:<a href=\"https://doi.org/10.1007/s10928-020-09730-z\">10.1007/s10928-020-09730-z</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33389521/\">https://pubmed.ncbi.nlm.nih.gov/33389521</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D07AC01;
